Search This Blog

Tuesday, November 6, 2018

Jazz Pharmaceuticals reports Q3 adjusted EPS $3.58, consensus $3.32


Reports Q3 revenue $469M, consensus $482.48M.
https://thefly.com/landingPageNews.php?id=2818703
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)